The region of the colicin El polypeptide that interacts with immunity protein has been localized to a 168-residue COOH-terminal peptide. This is the length of a proteolytically generated peptide fragment of colicin El against which imm+ function can be demonstrated in osmotically shocked cells. The role of particular amino acids of the COOH-terminal peptide in the expression of the immune phenotype was studied. Chemical modification showed that the two histidine residues (His 427 and His 440) and the single cysteine residue (Cys 505) present in the COOH-terminal peptide were not necessary for the colicin-immunity protein interaction. The immunity protein was localized in the cytoplasmic membrane fraction, consistent with previous work of others on the colicin Ia immunity protein and the prediction from the immunity protein amino acid sequence that it is a hydrophobic protein. The distribution of hydrophobic residues along the immunity polypeptide was calculated.
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The 4.2-megadalton ColEl plasmid codes for both colicin El, a 57,000-Mr-dalton bactericidal protein that acts by deenergizing the cytoplasmic membrane of sensitive Escherichia coli, and an immunity protein that protects cells against the colicin (3) but that has not yet been isolated and purified. Colicin El first binds to the vitamin B12 receptor, the bfe gene product, located in the bacterial outer membrane (OM) (14) . The colicin subsequently forms a channel in the cytoplasmic membrane that is sufficiently permeable to small ions to collapse the membrane potential resulting in cell death (10, 12) . The mechanism by which the immunity protein prevents cell death in response to exogenous colicin is not understood.
The immunity protein has not been found to complex with extracellular colicin El as do the immunity proteins for colicins E2 and E3, which also use the vitamin B12 receptor (14) . Association of the respective immunity proteins with colicins E2 and E3 results in the formation of complexes that are inactive in vitro (16, 36) . Cellular immunity to colicins E2, E3, or colicin Ia, whose mode of action is similar to that of colicin El, was shown not to affect affinity for the receptor (19, 22) .
Molecular details of immunity in the channel-forming colicins have been studied most thoroughly for the I colicins (25, 42) . Colicin Tb, which uses the same OM receptor as does colicin Ta, can kill strains immune to colicin Ia (18) , showing that the immunity protein is specific to the colicin and does not involve a general change in the character of the cell that would confer immunity to all colicins. The colicin Ia immunity phenotype has been demonstrated in inner membrane vesicles, and a 14,000-to 15,000-Mr polypeptide associated with immunity has been localized in the inner membrane (IM) fraction of UV-irradiated cells (42) . It the survival of Ta-immune strains to Ta-Tb hybrid molecules (25) .
The present study was undertaken to define more precisely the immunity protein recognition domain of colicin El, to examine the role of particular amino acids in the immune response, and to test the hypothesis that, by analogy to the colicin Ia immunity system, the immunity protein to colicin El operates at the level of the cytoplasmic membrane. The immunity protein-reactive domain of the colicin El molecule was investigated with COOH-terminal peptide fragments of colicin El that have previously been defined and characterized (7) (8) (9) 11) . Digestion of colicin El with trypsin or thermolysin yields COOH-terminal fragments of 20,000 and 18,000 Mr, respectively, which encompass the channel-forming domain (7, 9, 11) and perhaps part of that involved in receptor binding (7) . If immunity operates at the level of the cytoplasmic membrane, the immunity phenotype should be displayed by osmotically shocked cells lacking a complete OM. Such shocked cells have been used previously to test the activity of colicin peptide fragments that did not exhibit killing activity in vivo because of the OM barrier (31, 39 Construction of plasmids isogenic except for the imm gene. The immunity protein structural gene was isolated from the plasmid pBR324 (5) purified from K12-294 (a gift from P. van den Elzen, Free University, Amsterdam) as described above. The plasmid was digested with the restriction endonucleases EcoRI (300 U/ml; Boehringer Mannheim Biochemicals, Indianapolis, Ind.) and NruI (300 U/ml; Boehringer Mannheim) in 50 mM Tris hydrochloride (pH 7.2)-50 mM NaCI-50 mM KCI-10 mM MgC12-5 mM 1-mercaptoethanol-0.2 ,ug of bovine serum albumin per ml at 37°C for 20 min. The digest was subjected to agarose gel electrophoresis on a 1% gel containing 1 ,ug of ethidium bromide per ml at 50 V for 1 h, and the 480-base-pair fragment including the immunity protein gene was then electroeluted to DEAE paper (50 V, 10 min). The DNA was washed from the paper by incubation with 1.5 M NaCl-10 mM Tris hydrochloride (pH 7.5)-i mM EDTA at 4°C for 18 h. The paper fragments were removed by centrifugation through glass wool. The ethidium bromide was extracted with isoamyl alcohol, and the DNA was then ethanol precipitated. The fragment was blunt ended by the T4 polymerase end-labeling system (Bethesda Research Laboratories, Inc., Gaithersburg, Md.) according to the instructions of the manufacturer.
The vector pKK223-3 (P-L Biochemicals, Inc., Milwaukee, Wis.) was digested with the restriction endonuclease SmaI (200 U/ml; Boehringer Mannheim) in 20 mM KCI-6 mM Tris hydrochloride (pH 8.0)-6 mM 3-mercaptoethanol at 25°C for 30 min. The SmaI was inactivated by heating to 65°C for 10 min, and the digest was extracted twice with 1:1 phenol-chloroform followed by three extractions with diethyl ether. The linearized vector was precipitated by the addition of sodium acetate and ethanol and was redissolved in 10 mM Tris hydrochloride (pH 8.0)-i mM EDTA at a concentration of 200 ,ug/ml. SmaI-cut pKK223-3 was mixed with the blunt-ended imm gene fragment in a 3:1 molar ratio and was ligated (T4 ligase; Boehringer Mannheim) in 20 mM Tris hydrochloride (pH 8.0)-10 mM MgC12-10 mM dithiothreitol-0.6 mM ATP-15% polyethylene glycol (Sigma Chemical Co., St. Louis, Mo.) at 12°C for 70 min followed by 4°C for 18 h. The high-molecular-weight concatemers formed by this ligation were isolated by centrifugation and cleaved to unit length by digestion with the restriction endonuclease PstI (200 U/ml; Boehringer Mannheim) in 50 mM NaCI-10 mM Tris hydrochloride (pH 7.5)-10 mM MgC12-1 mM dithiothreitol at 37°C for 1 h. After heat inactivation of the PstI at 65°C for 15 min, the digest was extracted twice with 1:1 phenol-chloroform and twice again with diethyl ether. The resultant products were diluted fourfold and were ligated (T4 ligase; Boehringer Mannheim) as above except that polyethylene glycol was not added. The ligase was heat inactivated at 65°C for 15 min and extracted with phenol-chloroform and diethyl ether as described above, and the DNA was precipitated by the addition of sodium acetate and ethanol. After being redissolved in 10 mM Tris hydrochloride (pH 8.0)-i mM EDTA, any plasmid that did not contain an insert, i.e., any still containing a site for the restriction endonuclease SmaI, was linearized by digestion with SmaI as described above. The digest was transformed into E. coli JM83 and DR1984, which were made competent by the calcium chloride procedure (23) . A portion of the transformation mix was inoculated into 10 ml of L broth containing 37 ,ug of ampicillin per ml and was grown at 37°C overnight. The cells were diluted 10-fold the following morning, allowed to grow for 1 h at 37°C, and subjected to selection against colicin El (36 ng/ml). The resultant culture was diluted and plated onto 1.4% agar plates containing 37 ,ug of ampicillin per ml. Fifteen resultant single colonies were selected for further analysis. The resultant clones were screened for the presence of the immunity protein insert by digestion with BamHI (as described above) and 1% agarose gel electrophoresis. The clones were screened for the orientation of the insert relative to the tac promoter by digestion of DNA isolated as described from 16 insert-containing clones with the restriction endonucleases PstI and Sau3A (150 and 100 U/ml; Boehringer Mannheim) under conditions described for PstI digestion and 1.3% agarose gel electrophoresis. One clone with the immunity protein gene inserted in the opposite orientation relative to the tac promoter was selected for this study.
Preparation of colicin El and its proteolytic fragments. Colicin El was prepared from strain JC411 by the method of Cleveland et al. (9) . The purified colicin was dialyzed against 100 mM potassium phosphate (pH 7.0) and stored at 4°C. The 20,000-Mr COOH-terminal tryptic peptide of colicin El was prepared by digestion of -15 mg of colicin El (trypsincolicin, 1:250 molar ratio, 26°C) and was purified by gel permeation through a 2.5-by 10-cm Sephadex G-100 column as previously described (11) . The 18,000-Mr COOH-terminal thermolytic peptide was prepared by digestion of colicin El with a 1:125 (wt/wt) ratio of thermolysin to colicin and was purified by gel permeation through a 1-by 25-cm Sephadex G-75 column as previously described (7, 31) . Eluted thermolytic and tryptic peptides were detected by A280, and the purity of the eluted peptides was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with 12.5% acrylamide and 0.33% bisacrylamide.
Cysteine modification of colicin El. Colicin El in 0.1 M potassium phosphate (pH 7.0) was mixed with 8 M urea to yield a final urea concentration of 6 M, and the pH of the solution was then adjusted to 8.0 with NaOH. The colicin El in urea was allowed to incubate with 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB, Sigma; colicin-DTNB [1:100]) for 16 h at 22°C. Upon sulfhydryl group modification there is a stoichiometric release of thionitrobenzoate anion, which was monitored at 412 nm (EM = 1.36 x 104 M-1 cm-') to determine the concentration of reactive cysteine residues (26) . Unmodified controls were incubated as described above with 6 M urea. DTNB-modified and control colicin El were dialyzed three times against 1 liter of 0.1 M potassium phosphate (pH 7.0) before assay of activity.
Histidine modification of the proteolytic fragment of colicin El. The COOH-terminal tryptic peptide (0.65 mg/ml) in 0.1 M potassium phosphate (pH 7.0) was incubated at 25°C with 0.12 mM diethylpyrocarbonate (DEP) for 20 min. DEP was first diluted into anhydrous ethanol, and the effective concentration was determined by reaction with 10 mM imidazole (pH 7.5) (27) . The modification reaction was monitored spectrophotometrically between 320 and 230 nm, and the extent of the reaction was calculated from the extinction coefficient (EM = 3,200 M-1 cm-') of the carbethoxy histidyl residues at 238 nm (28) .
Survival of osmotically shocked cells. E. coli W3110 bfecells were grown and subjected to osmotic shock with the omission of EDTA (30) . Cells were plasmolyzed in 20% (wt/vol) sucrose-33 mM Tris hydrochloride (pH 7.1) and were centrifuged at 13,000 x g for 10 min at 4°C. Colicin El or COOH-terminal colicin peptide, in volumes specified below (see Fig. 1 through 4) , was placed on the wall of the tube containing the well-drained, plasmolyzed cell pellet.
Ice-cold MgCl2 (3 x 10-4 M, 4 ml) was rapidly pipetted into the tube during vortexing. Osmotically shocked cells were then incubated at 0°C for 15 min, diluted into L broth, and spread onto L broth plus 1.5% agar plates. To assay survival in the absence of colicin or derived peptides, buffer or colicin that had been heat denatured by boiling for 10 min was placed on the wall of the tube.
Subcellular localization of plasmid-encoded protein. The localization of the plasmid-encoded immunity protein was identified in the maxicell strain DR1984 by the method of Sancar et -al. (34) . After 1 h of sulfur starvation in M-9 medium, 10-ml cultures of UV-irradiated and cycloserinetreated (100 jig/ml) maxicells were labeled by a 1-h incubation with 10 pLCi of [35S]methionine per ml, harvested by centrifugation at 4,000 x g for 10 min, washed with sulfurfree buffer, and resuspended in 0.5 ml of 0.75 M sucrose-10 mM Tris acetate (pH 8.0). Lysozyme was added to a final concentration of 6 ,ug of original cell culture per ml, and the cell suspension was incubated on ice for 5 min. Spheroplasts were made by the gradual addition of 1 ml of 1.5 mM EDTA over a 5-min period, followed by disruption by osmotic shock as the cell suspension was poured into 6 ml of ice-cold H20, stirred for 10 min, and then centrifuged at 1,200 x g for 10 min to remove unlysed cells in the presence of phenylmethylsulfonyl fluoride (0.5 mM) as a protease inhibitor. Membranes were sedimented by centrifugation at 80,000 x g for 4 h or (Fig. 2C ) for 2 h. The supernatant, containing periplasmic and cytoplasmic proteins, was precipitated by the addition of bovine serum albumin (100 ,ug) and trichloroacetic acid, and then centrifuged at 12,000 x g for 30 min. The pellet was washed in acetone, dried under N2, and dissolved in 10 mM Tris-NaOH (pH 8.0). For solubilization with sodium lauryl sarcosinate (sarcosyl; Sigma), the membrane pellet was washed with 10 mM Tris acetate (pH 8.0)-S5 mM EDTA, sedimented as above, frozen overnight, and suspended in the above wash buffer with the addition of sarkosyl to a final concentration of 1% (15) . For solubilization with Triton X-100, the pellet was washed with 10 mM Tris acetate (pH 8.0-30 mM MgCl2, sedimented, frozen overnight, and resuspended with 2% Triton X-100 (13) . The membranes were incubated at room temperature in the presence of detergent for 30 min to solubilize the IMs, and the OM was sedimented by centrifugation at 80,000 x g for 4 h. Protein samples were prepared by boiling in a solubilizing mix containing 8 M urea and 4% sodium dodecyl sulfate before analysis on sodium dodecyl sulfate gels containing 15% polyacrylamide.
RESULTS
Expression of immunity against COOH-terminal peptides.
Cells of strain W3110 bfe-harboring either pHSG215 (imm+) or pBR322 (imm-) were killed by colicin El, colicin COOH-terminal peptide, or chemically modified COOHterminal peptide, if present during osmotic shock (Fig. 1) . In all cases, colicin El or its COOH-terminal peptides were capable of killing cells under conditions of osmotic shock in nonimmune strains, with a high degree of protection against lethality afforded by the presence of the immunity protein. Plasmid pBR322, coding for tetracycline and ampicillin resistance proteins but not the immunity protein, had no effect on colicin El immunity when compared with strains harboring no plasmid (data not shown).
Immunity to the channel-forming domain of colicin El is demonstrated in Fig. 1A (Fig. 1A) . The survival levels of cells shocked in the presence of 10 nM, 100 nM, and 1 ,uM COOH-terminal colicin peptide prepared by proteolytic cleavage with thermolysin (7) were 2, 0.2, and 0.01%, respectively, for W3110(pBR322), compared with 85, 60, and 1.5% for W3110(pHSG215) (Fig. 1B) . Also apparent was the inability of immunity protein to protect against high levels of colicin El, analogous to the immunity breakdown observed at high concentrations of membrane-depolarizing colicin Ia or lb (21) . Survival levels of cells shocked in the presence of a slightly larger 20,000-Mr peptide prepared by cleavage of colicin with trypsin (11), 1 and 50% for W3110(pBR322) and W3110(pHSG215), respectively, in the presence of 1 ,uM peptide, were higher than those shocked in the presence of colicin El or thermolytic peptide (Fig. 1C) .
Chemical modification of COOH-peptide and effect on immunity. Histidine and cysteine residues could be involved in specific association of the colicin and immunity proteins through hydrogen bonding or disulfide bridges, respectively. Chemical modification by DEP of the two histidines His 427 and His 440 in the channel-forming domain did not significantly alter the lethal effect of the tryptic peptide or protection by the immunity protein, implying no critical role for these residues in the immune response (Fig. 1D) . Chemical modification of the single cysteine molecule, Cys 505, with the Ellman reagent DTNB after denaturation in urea resulted in a small decrease in activity of the tryptic peptide in W3110(pBR322), but did not inhibit protection by the immunity protein in W3110(pHSG215), and urea treatment of the peptide followed by dialysis before assay of activity had no effect on activity (Fig. 1E ).
Cellular localization of the immunity protein. The localization of the immunity protein was approached by labeling maxicells with [35S]methionine and examining the distribution of labeled plasmid-encoded proteins in cellular fractions separated by centrifugation and the use of two different detergent systems, Sarkosyl and Triton X-100, to separate IM and OM fractions (13, 15) . The separation, as judged by the polypeptide pattern in lanes 1 and 2 (IM) and 3 and 4 (OM) of Coomassie blue-stained polypeptides in fractions separated with sarcosyl ( Fig. 2A) , is similar to that previously reported by others (1, 35) . The IM and OM fractions show a different distribution of polypeptides, with a larger number of the IM fraction. Given the large number of polypeptides, however, and the lack of resolution of onedimensional gels, the quality of the separation should be judged by examination of polypeptides with known locations. Such a group of polypeptides is provided by the tetracycline resistance gene product (37,000 Mr [34] ), which is located in the IM (24), and secreted P-lactamase responsible for ampicillin resistance (31,000 and 28,000 Mr in plasmid pBR322 and 28,000 Mr in pKK223-3 [6, 37] ), which is located in the periplasm (24) . Incorrectly processed ,Blactamase should be localized in the IM. Examination of the plasmid-encoded proteins in fluorograms (Fig. 2B, C, and E) shows that the tet protein is almost exclusively found in the IM fraction, as compared with the OM, and that ,B-lactamase is found in the soluble fraction (Fig. 2C) , as predicted for well-separated fractions. The different forms of ,-lactamase were found in the soluble and IM fractions, with negligible amounts in the OM component (Fig. 2B ). The separation with Triton X-100 gave a larger yield of OM relative to IM (Fig. 2D) . In this case, some forms of P-lactamase were seen in the OM fraction, but definitely less than were seen in the IM, and the dominant 30,000Mr form was again seen in the soluble fraction (Fig. 2E) . Unidentified According to the nucleotide sequence, the molecular weight of the immunity protein is 13.3 kilodaltons. Comparing the odd-numbered lanes (1, 3, and 5 ) corresponding to imm+ plasmid with the even-numbered lanes (2, 4, and 6 ) for imm-, a well-defined band at 13,000 Mr was seen in the sarcosyl-separated IM fraction of Fig. 2B , where protein products of plasmids isogenic except for imm were compared. Figure 2C compares the two plasmids used in the osmotic shock and chemical modification experiments of Fig. 1 , which were not isogenic. A broad band at approximately 13,000 Mr was again seen in the sarcosyl-separated IM fraction of the imm+ pHSG215 plasmid, and a diffuse band of somewhat lower molecular weight was seen in the IM fraction of the imm-pBR322 (Fig. 2C) . It was concluded that the immunity protein is localized in the IM fraction. A very low-molecular-weight polypeptide, the smallest on the fluorogram, was also seen in the imm+ lane (lane 5) of the soluble fraction from both sarcosyl-and Triton X-100-separated material (Fig. 2D and E, respectively) . This polypeptide is either derived from proteolysis of the imm protein or is possibly a product of transcription under the tac promoter. The 12,000-Mr band also seen in the soluble fraction ( Fig. 2D and E) was not related to the immunity protein since this band was found in the imm-and the imm+ lanes (lanes 6 and 5).
Putative amino acid sequence of the colicin El immunity protein. Analysis of the amino acid sequence of the El immunity protein derived from the nucleotide sequence predicts that the immunity polypeptide has properties of a membrane protein. The gene coding for colicin El immunity has been identified and localized in a 1.6-kilobase-pair plasmid, PA02, derived from the ColEl plasmid (32) . When the nucleotide sequence of PA02 is read in each direction in each of the three possible reading frames, the two largest protein sequences are a 45-residue polypeptide that is probably responsible for cell lysis and release of colicin after induction of colicin production (38) , and a 113-residue protein corresponding to a nucleotide sequence previously identified as coding for the immunity protein (32) . The primary amino acid sequence of the 113-residue polypeptide is shown in Fig. 3 . The following evidence implies that the sequence shown in Fig. 3 is that of the imm gene product. Its size is consistent with the observation that a 360-base-pair mRNA is synthesized in vitro from PA02 (29) . The choice of an initiation site used in the present work is the same as that proposed by Patient (33) to initiate transcription of an imm gene product. The molecular weight of this protein, 13.3 kilodaltons, is consistent with the observation in E. coli minicells that colicin El immunity is correlated with the presence of an -13,000-to 14,000-Mr polypeptide (17; Fig.  2B , D, and E). The amino acid sequence of the immunity protein is generally hydrophobic, consistent with its localization in the cytoplasmic membrane.
DISCUSSION
The mechanism of action of the immunity protein on the group of membrane-depolarization colicins has yet to be elucidated. There is no decrease in adsorption of colicins to OM receptors in immune strains (19, 22) . The colicin Ta immunity protein and phenotype were found to be located in the IM fraction. By analogy, one would predict that the colicin El immunity protein would be located in the IM, the target of colicin El action. The immune phenotype should then be demonstrable in osmotically shocked cells, which have been used previously in studies of colicin action (31, 39) , and which allow a bypass of receptor-mediated OM resistance to colicin action without release of cytoplasmic or IM constituents (30) . Cells tolerant to colicin E3 because of changes in OM proteins can be killed by this colicin under conditions of osmotic shock, whereas IM-mediated tolerance to colicin L cannot be overcome by the shock (39). Thus, it has been documented that conditions of osmotic shock can bypass OM receptor-mediated resistance or tolerance to colicin action, but not tolerance mediated by the cytoplasmic membrane. In the present work the immune phenotype could be demonstrated in response to colicin El addition in osmotically shocked cells harboring the plasmid pHSG215 (imm+). This plasmid, which codes for the colicin El immunity protein and for ampicillin resistance, was selected to avoid the complicating effects of endogenous colicin El and lysis protein production (38) . To localize the region of interaction with immunity protein in the colicin polypeptide, defined COOH-terminal peptides from the channel-forming domain were used to challenge shocked cells.
The channel-forming region was found to be localized in COOH-terminal tryptic (11), thermolytic (7) , or cyanogen bromide (9) peptides with 20,000, 18,000, or 16,000 Mr, respectively. The activities of two thermolytic fragments containing the colicin El COOH terminus "Th 1," the 18,000-Mr fragment used in Fig. 1B , and "Th 2," 39,000 Mr, have been studied previously in shocked bfe-cells (31) . Both fragments lack in vivo activity but possess killing ability under conditions of osmotic shock. The Th 1 peptide, like the tryptic peptide, lacks the receptor-binding function but contains the ionophoretic domain. Th 2 contains the receptor-binding and ionophoretic domains, and its lack of ability to kill in vivo has led to the proposal that the missing N-terminal third of the molecule is utilized in translocation of colicin El to the IM (31). The immunity-reactive domain of colicin Tb has been shown to reside in the COOH-terminal half of the protein (25) , which has been inferred, although not yet proved, to contain the channel-forming domain of colicin Ib. The present study has further localized the immunity recognition domain of colicin El to a 168-residue region spanned by the thermolytic peptide Th 1 defined by Ohno-Twashita and Imahori (31), extending from N-terminal amino acid residue Ile 345 to Lys 512 of the 522-residue colicin polypeptide.
The nature of the interaction between the COOH-terminal domain of the colicin El and immunity protein molecule is not known. A chemical modification study was done of particular amino acids in the colicin COOH-terminal peptides that are present in low stoichiometry and that could participate in H bonding or disulfide formation with the immunity protein. Only two histidines, His 427 and His 440, are present in the COOH peptide, and these can be converted with DEP to spectrophotometrically defined carbethoxy histidyl residues. The one cysteine molecule, Cys 505 in the COOH-terminal colicin peptide, could form disulfides with the immunity protein with a proposed sequence containing three cysteines (Fig. 3) . The DEP-and DTNB-modified tryptic peptides, previously shown not to be significantly altered in ionophoretic activity (L. J. Bishop, V. L. Davidson, and W. A. Cramer, Biophys. J. 45:62a, 1984), were employed to examine any possible role of the two histidines or single cysteine contained in the COOH-terminal peptide in the immune response. These residues were found not to be necessary for the interaction of the colicin El with its immunity protein.
Subcellular localization of the immunity protein demonstrated that it was present in the IM fraction of envelopes solubilized by two different detergent systems. The distribution of hydrophobic residues in the membrane-bound immunity protein was determined based on the amino acid sequence by the algorithm and free-energy values of Kyte and Doolittle (20) . A plot of this function reveals the presence of three hydrophobic domains (Fig. 4) other workers (2, 41) . The hydrophobicity index function shown in Fig. 4 contrasts with those obtained for the immunity proteins of colicin E3 and cloacin DF13 (40) , bacteriocins that inhibit protein synthesis in membrane-free systems in vitro. The amino acid sequences of the latter immunity proteins are hydrophilic and contain no apparent membrane-associated domain, which can be seen by inspection of the sequence or calculated as in Fig. 4 (data not  shown) . For the colicin El immunity protein, residues 1 through 54 and 81 through 113 are nonpolar (Fig. 4) and therefore are assumed to be membrane associated. Segments 1 through 25 and 34 through 54 are each of sufficient length to span the membrane. Residues 66 through 80 compose a hydrophilic domain that presumably extends into either the cytoplasm or the periplasm, depending upon the orientation of the protein in the IM. This hydrophilic domain contains an especially highly polar sequence of nine residues (66 through 74; K-K-D-F-F-E-R-R-K) in which there are seven charged residues and a net charge of +3. This unique group of charged residues may serve as an anchoring group for the membrane protein.
